Alpha-fetoprotein response at different time-points is associated with efficacy of nivolumab monotherapy for unresectable hepatocellular carcinoma

Nivolumab monotherapy has a modest objective response rate (ORR) in hepatocellular carcinoma (HCC). To overcome the lack of biomarkers that predict delayed alpha-fetoprotein (AFP) response beyond 4 weeks, we applied a novel 50-10 rule of AFP response for unresectable HCC patients under nivolumab mon...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Am J Cancer Res
Hlavní autoři: Teng, Wei, Lin, Chen-Chun, Ho, Ming-Mo, Lui, Kar-Wai, Wang, Sheng-Fu, Hsu, Chao-Wei, Lin, Shi-Ming
Médium: Artigo
Jazyk:Inglês
Vydáno: e-Century Publishing Corporation 2021
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8167682/
https://ncbi.nlm.nih.gov/pubmed/34094688
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky